跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,079 条关于
“Dermavon Holdings”
全部
1,079
临床试验
129
药物
64
机构
154
资讯
732
去年
China Medical System's MG-K10 Advances to Phase III Trials for Chronic Spontaneous Urticaria Treatment
9个月前
China Medical System's JAK1 Inhibitor Povorcitinib Receives Breakthrough Therapy Designation for Vitiligo Treatment
15天前
Lumirix® (Ruxolitinib Phosphate Cream) Approved in China for Mild-to-Moderate Atopic Dermatitis
去年
Sareum's SDC-1801 Advances to Phase II Trials for Psoriasis Following Positive Phase I Results
去年
European Commission Approves Novo Holdings' $16.5B Catalent Acquisition
2年前
Bio-Path Holdings' BP1003 Demonstrates Therapeutic Potential in Diverse Cancers
2年前
Immunocore and Bristol Myers Squibb Collaborate on Phase 3 Trial for Advanced Cutaneous Melanoma
去年
ALX Oncology's Evorpacept Shows Promise in Multiple Cancer Trials
去年
CERO Therapeutics' CER-1236 Receives FDA Clearance for Clinical Trials
去年
Organovo Appoints Norman Staskey as CFO, Advancing IBD and MASH Programs
第 1 页,共 74 页
上一页
下一页